Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRSU
2201
Pursuit Attractions and Hospitality Inc
PRSU
$1.31B
| $6.08M | ﹤0.01% |
166,050
-4,899
| -3% | -$175K |
|
2202
Amalgamated Financial
AMAL
$1.53B
| $6.07M | ﹤0.01% |
156,243
-10,764
| -6% | -$408K |
|
2203
BioCryst Pharmaceuticals
BCRX
$2.49B
| $6.07M | ﹤0.01% |
637,658
+29,666
| +5% | +$230K |
|
|
SEZL
2204
Sezzle
SEZL
$4.34B
| $6.07M | ﹤0.01% |
95,881
-2,555
| -3% | -$174K |
|
2205
Edgewise Therapeutics
EWTX
$4.8B
| $6.06M | ﹤0.01% |
192,434
-6,180
| -3% | -$178K |
|
|
ETOR
2206
eToro Group
ETOR
$2.27B
| $6.05M | ﹤0.01% |
+201,393
| New | +$6.16M |
|
2207
Celldex Therapeutics
CLDX
$3.29B
| $6.04M | ﹤0.01% |
190,399
-4,153
| -2% | -$113K |
|
2208
Immunome
IMNM
$3.09B
| $6.04M | ﹤0.01% |
276,066
+12,692
| +5% | +$282K |
|
2209
Invesco KBW Bank ETF
KBWB
$6.87B
| $6.03M | ﹤0.01% |
76,252
+1,403
| +2% | +$117K |
|
2210
Harmonic Inc
HLIT
$1.51B
| $6.03M | ﹤0.01% |
671,482
-23,479
| -3% | -$233K |
|
2211
Bank of N.T. Butterfield & Son
NTB
$2.51B
| $6.01M | ﹤0.01% |
117,936
-10,718
| -8% | -$550K |
|
2212
SandRidge Energy
SD
$520M
| $6M | ﹤0.01% |
368,148
-13,840
| -4% | -$224K |
|
|
INVX
2213
Innovex International
INVX
$2.18B
| $6M | ﹤0.01% |
246,158
-10,449
| -4% | -$262K |
|
2214
Blue Bird Corp
BLBD
$2.05B
| $6M | ﹤0.01% |
105,707
-2,142
| -2% | -$116K |
|
2215
Oil-Dri
ODC
$1.31B
| $6M | ﹤0.01% |
92,119
-6,187
| -6% | -$377K |
|
2216
XPEL
XPEL
$1.38B
| $6M | ﹤0.01% |
135,457
-2,673
| -2% | -$128K |
|
2217
United Parks & Resorts
PRKS
$2.04B
| $6M | ﹤0.01% |
183,568
-5,825
| -3% | -$204K |
|
2218
HighPeak Energy
HPK
$940M
| $5.99M | ﹤0.01% |
868,683
+55,955
| +7% | +$294K |
|
2219
Smith & Wesson
SWBI
$643M
| $5.99M | ﹤0.01% |
417,808
+3,884
| +0.9% | +$47.2K |
|
|
JAN
2220
Janus Living Inc
JAN
$6.62B
| $5.98M | ﹤0.01% |
+253,625
| New | +$5.94M |
|
2221
Insperity
NSP
$1.99B
| $5.97M | ﹤0.01% |
220,679
-2,554
| -1% | -$82.1K |
|
2222
Hillman Solutions
HLMN
$1.69B
| $5.95M | ﹤0.01% |
715,643
-17,554
| -2% | -$159K |
|
2223
Nabors Industries
NBR
$1.39B
| $5.94M | ﹤0.01% |
69,053
+2,231
| +3% | +$162K |
|
2224
CRA International
CRAI
$1.06B
| $5.94M | ﹤0.01% |
36,695
-3,366
| -8% | -$607K |
|
2225
Goosehead Insurance
GSHD
$2.35B
| $5.91M | ﹤0.01% |
138,605
-8,036
| -5% | -$449K |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.